Strange Kevin T 4
4 · Inari Medical, Inc. · Filed Feb 19, 2025
Insider Transaction Report
Form 4
Strange Kevin T
Chief Financial Officer
Transactions
- Disposition from Tender
Common Stock
2025-02-19−67,502→ 0 total - Disposition to Issuer
Stock Option
2025-02-19−11,761→ 0 totalExercise: $56.00→ Common Stock (11,761 underlying) - Disposition to Issuer
Stock Option
2025-02-19−5,293→ 0 totalExercise: $58.44→ Common Stock (5,293 underlying)
Footnotes (3)
- [F1]Pursuant to the Agreement and Plan of Merger (the "Merger Agreement"), dated January 6, 2025, by and among Stryker Corporation ("Parent"), Eagle 1 Merger Sub, Inc. ("Merger Sub"), and Inari Medical, Inc. ("Issuer") on February 19, 2025 (the "Effective Time"), Merger Sub merged with and into Issuer, with Issuer surviving as a wholly owned subsidiary of Parent upon consummation of the transactions contemplated by the Merger Agreement. At the Effective Time, each outstanding share of common stock of the Issuer ("Common Stock") was cancelled and converted into the right to receive $80.00 in cash (the "Merger Consideration"), without interest.
- [F2]Includes 50,246 restricted stock units ("RSUs"). At the Effective Time, each outstanding award of RSUs was canceled and converted into the right to receive an amount in cash equal to the product of the aggregate number of shares of Common Stock underlying such RSU immediately prior to the Effective Time, multiplied by the Merger Consideration.
- [F3]At the Effective Time, each outstanding option, whether vested or unvested, was cancelled and converted into the right to receive an amount of cash equal to the product of (i) the aggregate number of shares of Common Stock underlying such option immediately prior to the Effective Time, multiplied by (ii) the amount, if any, by which the Merger Consideration exceeds the exercise price per share of such option, subject to any applicable withholding taxes and in accordance with the terms of the Merger Agreement.